// App-Quantinova.ai

620 : Molecular features in tumors at time of progression on tebentafusp associated with overall survival (OS)

Researchers

Presenter

  • Emma Leach

Principal Investigators

  • Laura Collins

  • Alexander Greenshields Watson

  • Shaad Abdullah

  • Sarah Stanhope

  • Koustubh Ranade

Medical Centers

  • Immunocore Ltd, Abingdon, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • beta-2 microglobulin

  • Cluster of Differentiation 163

  • Major Histocompatibility Complex, Class I, A

Drug/Treatment

  • GP100

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02570308

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved